Past history of hepatocellular carcinoma is an independent risk factor of treatment failure in patients with chronic hepatitis C virus infection receiving direct-acting antivirals-Reference-Cited by-同舟云学术

Past history of hepatocellular carcinoma is an independent risk factor of treatment failure in patients with chronic hepatitis C virus infection receiving direct-acting antivirals

Published:2018-08-30 Issue:12 Volume:25 Page:1462-1471
ISSN:1352-0504
Container-title:Journal of Viral Hepatitis
language:en
Short-container-title:J Viral Hepat

Author:

Sugiura Ayumi¹,Joshita Satoru¹²,Umemura Takeji¹²^ORCID,Yamazaki Tomoo¹,Fujimori Naoyuki¹,Kimura Takefumi¹,Matsumoto Akihiro¹³,Igarashi Koji⁴,Usami Yoko⁵,Wada Shuichi⁶,Mori Hiromitsu⁶,Shibata Soichiro⁶,Yoshizawa Kaname⁷,Morita Susumu⁷,Furuta Kiyoshi⁸,Kamijo Atsushi⁸,Iijima Akihiro⁹,Kako Satoko⁹,Maruyama Atsushi¹⁰,Kobayashi Masakazu¹¹,Komatsu Michiharu¹¹,Matsumura Makiko¹²,Miyabayashi Chiharu¹³,Ichijo Tetsuya¹⁴,Takeuchi Aki¹⁵,Koike Yuriko¹⁶,Gibo Yukio¹⁷,Tsukadaira Toshihisa¹⁸,Inada Hiroyuki¹⁹,Kiyosawa Kendo²⁰,Tanaka Eiji¹

Affiliation:

1. Department of Medicine; Division of Gastroenterology and Hepatology; Shinshu University School of Medicine; Matsumoto Japan

2. Research Center for Next Generation Medicine; Shinshu University; Matsumoto Japan

3. Consultation Centers for Hepatic Diseases; Shinshu University Hospital; Matsumoto Japan

4. Bioscience Division; TOSOH Corporation; Ayase Japan

5. Department of Laboratory Medicine; Shinshu University Hospital; Matsumoto Japan

6. Department of Gastroenterology; Japanese Red Cross Society Nagano Hospital; Nagano Japan

7. Department of Gastroenterology; National Hospital Organization; Shinshu Ueda Medical Center; Ueda Japan

8. Department of Gastroenterology; National Hospital Organization; Matsumoto Medical Center; Matsumoto Japan

9. Department of Internal Medicine; Nagano Prefectural Kiso Hospital; Kiso Japan

10. Department of Gastroenterology; Ina Central Hospital; Ina Japan

11. Department of Gastroenterology; Japanese Red Cross Society Suwa Hospital; Suwa Japan

12. Department of Gastroenterology; Nagano Chuo Hospital; Nagano Japan

13. Department of Gastroenterology; Chikuma Central Hospital; Chikuma Japan

14. Department of Gastroenterology; Japanese Red Cross Society Azumino Hospital; Azumino Japan

15. Aki Naika Clinic; Saku Japan

16. Kawanakajima Clinic; Nagano Japan

17. Gibo Hepatology Clinic; Matsumoto Japan

18. Department of Gastroenterology; Kenwakai Hospital; Iida Japan

19. Kanebako Internal Medicine Clinic; Nagano Japan

20. Gastroenterology Center; Aizawa Hospital; Matsumoto Japan

Funder

Japan Society for the Promotion of Science

Promotion Project of Education, Research, and Medical Care from Shinshu University Hospital

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jvh.12973/fullpdf

Reference39 articles.

1. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus;Kiyosawa;Hepatology,1990

2. Understanding the hepatitis C virus life cycle paves the way for highly effective therapies;Scheel;Nat Med,2013

3. Global control of hepatitis C: where challenge meets opportunity;Thomas;Nat Med,2013

4. Natural history of acute hepatitis C;Tanaka;J Gastroenterol Hepatol,2000

5. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection;Fried;N Engl J Med,2002

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. C型肝炎キャリア拾い上げにおいて，HCV抗体陽性者に対して残血清を用いたHCVコア抗原測定法併用の臨床的有用性;Kanzo;2023-12-01

2. Efficacy and Safety of Direct-Acting Antivirals in Elderly Patients with Chronic Hepatitis C: A Nationwide Real-Life, Observational, Multicenter Study from Turkey;The Turkish Journal of Gastroenterology;2022-10-06

3. Quantitative changes of lipoprotein(a) in chronic hepatitis C patients achieving a sustained virological response by direct-acting antivirals;Clinics and Research in Hepatology and Gastroenterology;2022-10

4. The Impact of Antiviral Therapy for Hepatitis C Virus on the Survival of Patients after Hepatocellular Carcinoma Treatment;Internal Medicine;2022-09-15

5. Long-term prediction of hepatocellular carcinoma using serum autotaxin levels after antiviral therapy for hepatitis C;Annals of Hepatology;2022-03